Orthofix launches OsteoCove bioactive synthetic graft : vima

Orthofix today announced it received FDA 510(k) clearance for its OsteoCove bioactive synthetic graft.

Related Keywords

Biologics Tyler Lipshultz , Frank Vizesi , , Orthofix Chief Scientific Officer Frank , Global Biologics Tyler Lipshultz ,